Cargando…
Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19
Autor principal: | Jolobe, Oscar M.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141265/ https://www.ncbi.nlm.nih.gov/pubmed/34059386 http://dx.doi.org/10.1016/j.ajem.2021.05.053 |
Ejemplares similares
-
Vaccination and Thrombotic Thrombocytopenic Purpura
por: Yavaşoğlu, İrfan
Publicado: (2020) -
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
por: Sissa, Cinzia, et al.
Publicado: (2021) -
Thrombotic thrombocytopenic purpura after vaccination for COVID-19: lesson for the clinical nephrologist
por: Özcan, Fedai, et al.
Publicado: (2022) -
COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes
por: Allas, Gewil Daniella Olipas, et al.
Publicado: (2022) -
Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
por: Alislambouli, Mawaddah, et al.
Publicado: (2021)